Registration successful.
Account activated – Pending validation
Your account has been activated successfully, but we still need to validate you as a UK healthcare professional. We’ll send you an email with the result. Please note this could take up to 10 days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website.
Important supply updates
At this time, COVID-19 is not having an impact on GSK supply in the UK.
Please see below for details of products where we are currently experiencing supply issues:
Product name |
PIP Code |
Status |
Estimated recovery date |
|---|---|---|---|
| BETNOVATE RD OINT 0.025% 100G UK-GSK | 485227 | OUT OF STOCK | EARLY AUGUST 2021 |
| CUTIVATE OINT 0.005% 30G X 1 TUBE UK-GSK | 3470093 | OUT OF STOCK | EARLY AUGUST 2021 |
| DERMOVATE CRM 0.05% 30G UK-GSK | 141838 | OUT OF STOCK | EARLY AUGUST 2021 |
| DERMOVATE OINT 0.05% 30G UK-GSK | 141895 | OUT OF STOCK | EARLY AUGUST 2021 |
| DERMOVATE OINT 0.05% 100G UK-GSK | 369785 | OUT OF STOCK | EARLY AUGUST 2021 |
| EUMOVATE OINT 0.05% 30G UK-GSK | 143214 | OUT OF STOCK | EARLY AUGUST 2021 |
| ENGERIX B PAEDIATRIC PFS X 1 NFN | 2894590 | RESTRICTED SUPPLY | EARLY OCTOBER 2021 |
| FENDRIX CCT + 1N FS GP-IE-NO-S | 3164159 | RESTRICTED SUPPLY | NOVEMBER 2021 |
| FORTUM INJECTION 1G | 381988 | OUT OF STOCK | EARLY JAN 2022 |
| FORTUM INJECTION 2G | 385278 | OUT OF STOCK | EARLY JAN 2022 |
| FORTUM INJECTION 500mg | 434092 | OUT OF STOCK | EARLY JAN 2022 |
| INFANRIX IPV+HIB+2N FS | 3243839 | OUT OF STOCK | EARLY DECEMBER 2021 |
| VARILRIX VIAL +DIL.PRTC FS | 705320 | RESTRICTED SUPPLY | EARLY OCTOBER 2021 |
If you have any queries about the availability of a product, please contact your wholesaler.
Further information
If you require further information, please contact our UK Customer Contact Centre (customercontactuk@gsk.com); chat to a member of our team online.
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441.
